We are live on ! Find out more
AP

Alydar Partners Portfolio holdings

AUM $185M
1-Year Est. Return 42.33%
This Fund
S&P 500
This Quarter Est. Return
+14.07%
1 Year Est. Return
+42.33%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.86B
AUM Growth
–
Cap. Flow
+$1.72B
Cap. Flow %
92.68%
Top 10 Hldgs %
40.67%
Holding
103
New
101
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$77.1M
2
GME icon
GameStop
GME
+$65.5M
3
ETN icon
Eaton
ETN
+$57.2M
4
URI icon
United Rentals
URI
+$49.2M
5
WOLF icon
Wolfspeed
WOLF
+$38.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.2%
2 Technology 11.03%
3 Healthcare 6.68%
4 Industrials 6.31%
5 Communication Services 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASYS icon
101
Amtech Systems
ASYS
$291M
$636K 0.03%
+100,000
New +$448K
1 2 3 4
5

Similar funds

UPA
Union Point Advisors San Mateo, California $194M AUM 27.93% 1-Year Est. Return
CBCM
Charter Bridge Capital Management New York $170M AUM 13.25% 1-Year Est. Return
HRIA
Haberer Registered Investment Advisor Cincinnati, Ohio $165M AUM 11.95% 1-Year Est. Return
PCM
Peg Capital Management Canaan, New Hampshire $207M AUM 0.69% 1-Year Est. Return
TA
TBP Advisors Purchase, New York $161M AUM 15.39% 1-Year Est. Return
GCM
Grandmaster Capital Management San Francisco, California $161M AUM 20.87% 1-Year Est. Return
MWAN
Mariner Wealth Advisors (NYC) Overland Park, Kansas $209M AUM
SIA
Stancorp Investment Advisers Portland, Oregon $212M AUM

Alydar Partners's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Alydar Partners, which disclosed 103 positions worth $1.86B. Its ten largest holdings account for 41% of the portfolio.

Its largest position is Gilead Sciences: 1,480,000 shares worth $75.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, followed by Technology and Healthcare.

  • Alydar Partners's largest Q2 2013 buy was Gilead Sciences: 1,480,000 shares worth $75.9M.
  • Alydar Partners's ten largest holdings make up 41% of its $1.86B portfolio in Q2 2013.
  • Alydar Partners disclosed 103 positions in Q2 2013, its first 13F filing on record.

Based on Alydar Partners's 13F filing for Q2 2013, filed 14 Aug 2013.